Healthcare planning software developer Hospital IQ secured $25m in a Baxter-led round while augmented reality platform developer Ubiquity6 and infant product retailer Mumzworld have been acquired.

The Cisco and Deutsche Telekom-backed interactive video advertising software provider will acquire an NYSE spot after the deal, valuing it at a $1.3bn pro-forma equity valuation.

CapitalG is in line to score an exit from the language learning app developer, which was valued at $2.4bn in its last funding round.

The Stanford spinout has gone public following a $238m IPO, after revealing that the university was also among the series B investors.

Karolinska Development-backed Biosergen has begun trading on the Nasdaq First Growth Market, having already undertaken a $5.9m offering earlier this month.

Suez Group has paid an undisclosed amount for water flow analytics provider Inflowmatix after investing $3.4m in the company in 2019.

Existing shareholder Suez Group has acquired Imperial College spinout Inflowmatix, providing exits to IP Group and Parkwalk Advisors.

Partly based on research at University of Washington, KenSci has agreed to an acquisition by Tegria for an undisclosed sum.

The Asahi Kasei and Shenzhen Hepalink-backed microbial detection system provider has amassed over $340m of funding before filing for an initial public offering.

The cancer drug developer is set to float on the Nasdaq Global Select Market, presenting an opportunity for strategic investors Pharmaron, Celgene, Amgen and Merck & Co to exit.